Bristol-Myers Squibb Company (BMY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Group 1 - The presentation features Bristol-Myers Squibb with CEO Chris Boerner and Chief Commercial Officer Adam Lenkowsky participating [1] - Terence Flynn, Morgan Stanley's U.S. biopharma analyst, is hosting the event [1] - The session will include opening remarks followed by a Q&A segment [2]